These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 24277456)
1. The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors. Juliachs M; Muñoz C; Moutinho CA; Vidal A; Condom E; Esteller M; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F Clin Cancer Res; 2014 Feb; 20(3):658-67. PubMed ID: 24277456 [TBL] [Abstract][Full Text] [Related]
2. Re: The PDGFRβ-AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors. Richie JP J Urol; 2015 Jul; 194(1):117. PubMed ID: 26088228 [No Abstract] [Full Text] [Related]
3. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors. Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025 [TBL] [Abstract][Full Text] [Related]
4. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT. Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer. Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223 [TBL] [Abstract][Full Text] [Related]
6. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways. Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028 [TBL] [Abstract][Full Text] [Related]
8. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties. Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998 [TBL] [Abstract][Full Text] [Related]
9. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo. Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949 [TBL] [Abstract][Full Text] [Related]
10. IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer. Cortés-Sempere M; de Miguel MP; Pernía O; Rodriguez C; de Castro Carpeño J; Nistal M; Conde E; López-Ríos F; Belda-Iniesta C; Perona R; Ibanez de Caceres I Oncogene; 2013 Mar; 32(10):1274-83. PubMed ID: 22543588 [TBL] [Abstract][Full Text] [Related]
11. ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor. Juliachs M; Castillo-Ávila W; Vidal A; Piulats JM; Garcia Del Muro X; Condom E; Hernández-Losa J; Teixidó C; Pandiella A; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F Int J Cancer; 2013 Jul; 133(1):235-46. PubMed ID: 23292912 [TBL] [Abstract][Full Text] [Related]
12. Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors. Juliachs M; Vidal A; Del Muro XG; Piulats JM; Condom E; Casanovas O; Graupera M; Germà JR; Villanueva A; Viñals F BMC Cancer; 2013 Aug; 13():382. PubMed ID: 23937707 [TBL] [Abstract][Full Text] [Related]
13. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression. Su J; Zhang F; Li X; Liu Z Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260 [TBL] [Abstract][Full Text] [Related]
14. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line. Spierings DC; de Vries EG; Vellenga E; de Jong S Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464 [TBL] [Abstract][Full Text] [Related]
16. The role of reactive oxygen species in cisplatin-induced apoptosis in human malignant testicular germ cell lines. Schweyer S; Soruri A; Heintze A; Radzun HJ; Fayyazi A Int J Oncol; 2004 Dec; 25(6):1671-6. PubMed ID: 15547704 [TBL] [Abstract][Full Text] [Related]
17. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway. Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691 [TBL] [Abstract][Full Text] [Related]
18. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance. Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044 [TBL] [Abstract][Full Text] [Related]
19. Activation of PI3K/AKT and MAPK pathway through a PDGFRβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma. Li QL; Gu FM; Wang Z; Jiang JH; Yao LQ; Tan CJ; Huang XY; Ke AW; Dai Z; Fan J; Zhou J PLoS One; 2012; 7(3):e33379. PubMed ID: 22428038 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo. Zhang LL; Zhang J; Shen L; Xu XM; Yu HG Mol Med Rep; 2013 May; 7(5):1387-90. PubMed ID: 23546174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]